Radiopharmaceutical Market 2018 by Top Leading Vendors Life Sciences Ltd., Siemens AG, Sun Pharmaceutical Industries Ltd., Bayer AG, Cardinal Health Inc., Medtronic etc. Outlook 2023

Radiopharmaceutical Market Information: Type (Diagnostic Type, Therapeutic Type), Type of Test (Myocardial Perfusion Scan, Lung Scan, Others), Application (Oncology, Cardiology, Others), Route of Administration, End-User– Global Forecast (2017-2023)

The global radiopharmaceutical market is expected to grow at a CAGR of 8.7% during the forecast period 2017–2023.

KEY PLAYERS FOR RADIOPHARMACEUTICAL MARKET                       

Life Sciences Ltd., Siemens AG, Sun Pharmaceutical Industries Ltd., Bayer AG, Cardinal Health Inc., Medtronic, General Electric Company (GE Healthcare), Lantheus Medical Imaging, Inc., Advanced Accelerator Applications S.A., Mallinckrodt Pharmaceuticals, Nordion, Inc., Canadian Nuclear Laboratories (CNL), Bracco Diagnostic Inc., IBA Dosimetry GmbH, Avid Radiopharmaceuticals and few others.

Get Sample Report @ https://www.marketresearchfuture.com/sample_request/1650 .

MARKET HIGHLIGHTS FOR RADIOPHARMACEUTICAL MARKET            

As the healthcare industry is moving towards the personalized approaches, the role of radiopharmaceutical is also increasing. The radiopharmaceutical is acting as an all-rounder radiopharmaceutical from diagnosis to treatment for various chronic diseases such as cancers and other neurological disorders, which has provided an impetus to the market. Demand for radiopharmaceuticals is growing due to raising awareness about the availability of radiation and radioisotopes in medicine, particularly for diagnosis and therapy for various chronic conditions. In developed countries about one person in 50 uses diagnostic nuclear medicine every year, and the demand for therapy with radioisotopes is about one-tenth of this. Radiopharmaceuticals use radiation to provide diagnostic information about the functioning of a person's specific organs while radiotherapy can be used to treat some medical conditions, especially cancer, used to weaken or destroy particular targeted cells. 

The market’s growth is mainly attributed to the increasing prevalence of chronic diseases, which is creating a greater need for early diagnosis and treatment modules. Moreover, rising expenditure in oncology and growing emphasis on cancer management has also accelerated the market growth. However, the high cost of the device and low feasibility of treatment is undermining the potentials of the market to some extent. The risks associated with the use of radiopharmaceuticals also acts as a growth barrier for the market.

COMPETITIVE ANALYSIS FOR RADIOPHARMACEUTICAL MARKET

The market for Radio Pharmaceutical is characterized by the presence of several well-established and small players, the global market of Mobile Health appears to be highly competitive and fragmented. Major players are increasingly expanding their footprint in the emerging nations, making it putting pressure on the regional players, especially in terms of features such as type, product portfolios, and pricing. The market is witnessing intensified competition which is expected to get more intensified further during the forecast period. The market is witnessing intensified competition which is expected to get more intensified further during the forecast period. The global radiopharmaceutical market is experiencing extreme competition due to major companies are focusing on the development of new and advances drugs for diagnosis and treatment of various chronic diseases.

For instance, in January 2018, the company received U.S. Food and Drug Administration (FDA) approval of its new drug application (NDA) for LUTATHERA used for the treatment of somatostatin receptor positive gastroenteropancreatic neuroendocrine tumors.

In October 2017, the company announced the acquisition of SurgVision, a high-tech start-up developing a real-time Fluorescence Image Guided Surgery platform, to address an unmet medical need for oncology patients requiring tumor removal surgery.

Moreover, in January 2018, the company entered a partnership with F. Hoffmann-La Roche Ltd to develop integrated digital diagnostics platform to improve oncology and critical care treatment to accelerate and improve individualized treatment options for cancer and critical care patients.

In November 2017, the company entered into an agreement with Bruce Power to secure the long-term supply of Cobalt-60 for medical and other applications through the life of the four Bruce B reactors.

While in September 2017, The U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA) and NTP completed conversion of medical isotope molybdenum-99 (Mo-99) production process from highly enriched uranium (HEU) to low enriched uranium (LEU) in August.

Therefore, new product launches, acquisitions and agreements are some major strategies which has adopted by the global radiopharmaceuticals to upsurge the growth of the market.

Get Discount @ https://www.marketresearchfuture.com/check-discount/1650 .

TOP 5 REASONS TO GET THIS REPORT

Company profiling with detailed strategies, financials, and recent development activities
Market Strategic Business Influence Data
Market Research Future recommendations in key business segments based on the market estimations
Market share analysis of the top industry players
Market forecasts for a minimum of 5 years of all the mentioned segments, Trends and the regional markets With SWOT Analysis

MAJOR TOC FOR RADIOPHARMACEUTICAL MARKET RESEARCH REPORT – FORECAST TO 2023

CHAPTER 1. REPORT PROLOGUE

CHAPTER 2. EXECUTIVE SUMMARY

CHAPTER 3.MARKET INTRODUCTION

CHAPTER 4. RESEARCH METHODOLOGY

CHAPTER 5. MARKET DYNAMICS

CHAPTER 6. MARKET FACTOR ANALYSIS

LIST OF TABLES

TABLE 1 MARKET SYNOPSIS

TABLE 2 GLOBAL RADIOPHARMACEUTICAL MARKET, BY TYPE, 2014–2023 (USD MILLION)

TABLE 3 GLOBAL RADIOPHARMACEUTICAL MARKET FOR DIAGNOSTIC, BY TYPE, 2014–2023 (USD MILLION)

TABLE 4 GLOBAL RADIOPHARMACEUTICAL MARKET FOR SPECT RADIOPHARMACEUTICALS, BY TYPE, 2014–2023 (USD MILLION)

LIST OF FIGURE

FIGURE 1 GLOBAL RADIOPHARMACEUTICAL MARKET: MARKET STRUCTURE

FIGURE 2 TOP-DOWN & BOTTOM-UP APPROACH

FIGURE 3 DRIVERS & RESTRAINTS: GLOBAL RADIOPHARMACEUTICAL MARKET

FIGURE 4 PORTERS FIVE FORCES MODEL

FIGURE 5 VALUE CHAIN: RADIOPHARMACEUTICAL MARKET

Ask to Expert Inquire @ https://www.marketresearchfuture.com/enquiry/1650 .

About Us:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future, Office No. 528,
Amanora Chambers Magarpatta Road,
Hadapsar, Pune - 411028 Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.